TPST Tempest Therapeutics, Inc.

Fundamentals / CIK 0001544227 / USD

Tempest Therapeutics, Inc. reported $8.76M in total assets and a net loss of $40.59M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TPST in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$9.58M$4.79M$0-$79.14MFY 2016 Revenue: $653KFY 2016 Net Income: -$82.26M2016FY 2017 Revenue: $295KFY 2017 Net Income: -$84.58M2017FY 2018 Net Income: -$27.19M2018FY 2019 Net Income: -$44.57M2019FY 2020 Net Income: -$19.21M2020FY 2021 Net Income: -$28.30M2021FY 2022 Net Income: -$35.71M2022FY 2023 Net Income: -$29.49M2023FY 2024 Net Income: -$41.84M2024FY 2025 Net Income: -$26.26M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- -- -- -- -- -- $295K $653K
Cost of Revenue -- -- -- -- -- -- -- -- $790K $5.40M
Gross Profit -- -- -- -- -- -- -- -- -$495K -$4.75M
Research & Development $12.61M $28.48M $17.50M $22.53M $17.17M $14.39M $27.84M $14.43M $18.34M $21.64M
Selling, General & Admin -- -- -- -- -- -- -- -- $27.74M $49.22M
Total Operating Expenses -- -- -- -- -- -- -- -- $50.90M $81.67M
Operating Income -$26.57M -$42.03M -$29.16M -$34.64M -$26.99M -$19.30M -$45.40M -$26.87M -$84.33M -$81.01M
EBITDA -$26.31M -$41.64M -$28.78M -$34.00M -$26.61M -$18.96M -$45.30M -$26.84M -$82.68M -$78.77M
Interest Expense $207K $1.32M $1.45M $1.62M $1.28M $0 -- $134K $288K --
Income Before Tax -- -- -- -- -- -- -- -- -$50.91M -$82.06M
Income Tax Expense $0 $0 $0 $0 $0 $0 -- -- $67K $201K
Net Income -$26.26M -$41.84M -$29.49M -$35.71M -$28.30M -$19.21M -$44.57M -$27.19M -$84.58M -$82.26M
Basic EPS -$6.33 -$19.50 -$24.84 -$40.18 -$97.14 -$533.55 -$42.26 -$228.61 -$4,184.79 -$33.29
Diluted EPS -$6.33 -$19.50 -$24.84 -$40.18 -$97.14 -$533.55 -$42.26 -$228.61 -$4,184.79 -$33.29
Basic Shares Outstanding 4.1M 2.1M 1.2M 888.1K 291.5K 36.0K 1.1M 119.0K 20.2K 2.5M
Diluted Shares Outstanding 4.1M 2.1M 1.2M 888.1K 291.5K 36.0K 1.1M 119.0K 20.2K 2.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $207K $1.82M $114K $539K $570K $3.87M $7.63M $10.74M
Operating Income -$2.82M -$5.25M -$27.72M -$4.08M -$3.60M -$7.97M -$10.94M -$13.92M
EBITDA -$2.77M -$5.19M -$27.66M -$4.01M -$3.53M -$7.90M -$10.87M -$13.87M
Interest Expense -- $0 $0 $0 $0 $46K $161K $247K
Income Tax Expense -- $0 $0 $0 $0 $0 $0 $0
Net Income -$3.63M -$5.24M -$27.70M -$4.02M -$3.51M -$7.87M -$10.86M -$13.81M
Basic EPS -$0.21 -$0.34 -$2.53 -- -$0.79 -$2.07 -$3.16 --
Diluted EPS -$0.21 -$0.34 -$2.53 -- -$0.79 -$2.07 -$3.16 --
Basic Shares Outstanding 16.9M 15.2M 10.9M -- 4.4M 3.8M 3.4M --
Diluted Shares Outstanding 16.9M 15.2M 10.9M -- 4.4M 3.8M 3.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $7.71M $30.27M $39.23M $31.23M $51.83M $18.82M $62.48M $73.29M $17.58M $43.93M
Short-Term Investments -- -- -- -- -- -- -- $0 $51.50M $70.46M
Cash & Short-Term Investments $7.71M $30.27M $39.23M $31.23M $51.83M $38.70M $63.50M $77.70M $67.20M $114.4M
Other Current Assets $355K $535K $96K $263K $553K $59K -- -- -- --
Total Current Assets $8.27M $31.47M $40.36M $32.95M $68.96M $19.82M $71.13M $83.42M $19.74M $116.4M
Property, Plant & Equipment, Net $605K $886K $840K $1.06M $1.11M $1.11M -- -- $3.11M $5.57M
Other Non-Current Assets $517K $485K $448K $429K $111K $51K $507K $213K $74K $23K
Total Non-Current Assets $8.66M $10.01M $11.24M $13.14M $4.28M $3.04M $3.84M $652K $74K $6.10M
Total Assets $16.93M $41.49M $51.60M $46.09M $73.24M $22.86M $74.97M $84.07M $19.81M $122.5M
Accounts Payable $1.04M $2.45M $845K $1.11M $991K $1.07M $1.50M $2.00M $1.30M $2.18M
Short-Term Debt $0 $6.35M $4.29M -- -- $239K $208K $189K $174K --
Total Current Liabilities $3.31M $14.22M $9.41M $7.28M $20.03M $3.22M $12.52M $9.82M $4.09M $13.21M
Long-Term Debt -- $0 $6.26M $10.37M $15.07M $0 $168K $383K $599K --
Other Non-Current Liabilities -- -- -- -- -- $0 $16K $752K $751K $1.12M
Total Non-Current Liabilities $6.95M $8.14M $15.42M $20.70M $17.09M $1.73M $2.58M $1.14M $738K $1.12M
Total Liabilities $10.26M $22.36M $24.84M $27.98M $37.12M $4.95M $15.10M $10.95M $4.83M $14.32M
Total Debt (incl. Leases) $8.14M $15.37M $20.66M $22.11M $18.54M $2.61M $4.52M $572K $773K --
Common Stock $5.0K $3.0K $22K $11K $7.0K $1.0K $18K $13K $36K $36K
Retained Earnings -$233.4M -$207.1M -$165.3M -$135.8M -$100.1M -$71.76M -$208.7M -$164.1M -$136.9M -$250.2M
Accumulated Other Comp. Income -- -- -- -- -- $452K $165K $148K $8.0K -$60K
Total Stockholders' Equity $6.67M $19.13M $26.77M $18.11M $36.12M -$68.79M -$50.36M $70.95M -$130.7M $108.2M
Total Equity $6.67M $19.13M $26.77M $18.11M $36.12M -$68.79M $59.87M $73.12M -$128.5M -$51.20M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $897K $779K $1.80M $7.71M $7.51M $14.28M $21.51M $30.27M
Cash & Short-Term Investments $897K $779K $1.80M $7.71M $7.51M $14.28M $21.51M $30.27M
Other Current Assets $417K $417K $3.0K $355K $352K $482K $356K $535K
Total Current Assets $1.61M $1.70M $2.45M $8.27M $8.10M $15.10M $22.43M $31.47M
Property, Plant & Equipment, Net $429K $486K $545K $605K $681K $748K $817K $886K
Other Non-Current Assets $81K $501K $509K $517K $519K $529K $538K $485K
Total Non-Current Assets $7.15M $7.94M $8.30M $8.66M $9.03M $9.38M $9.73M $10.01M
Total Assets $8.76M $9.63M $10.75M $16.93M $17.13M $24.48M $32.16M $41.49M
Accounts Payable $2.03M $2.00M $585K $1.04M $922K $4.72M $2.19M $2.45M
Short-Term Debt -- -- -- $0 $0 $0 $4.19M $6.35M
Total Current Liabilities $4.67M $4.45M $3.31M $3.31M $3.52M $7.14M $13.18M $14.22M
Long-Term Debt -- -- -- -- -- -- $10K $0
Total Non-Current Liabilities $5.92M $6.27M $6.62M $6.95M $7.26M $7.56M $7.85M $8.14M
Total Liabilities $10.59M $10.72M $9.93M $10.26M $10.78M $14.70M $21.03M $22.36M
Total Debt (incl. Leases) $7.26M $7.56M $7.85M $8.14M $8.40M $8.66M $13.12M $15.37M
Common Stock $17K $16K $14K $5.0K $4.0K $4.0K $4.0K $3.0K
Retained Earnings -$278.9M -$275.3M -$270.1M -$233.4M -$229.3M -$225.8M -$218.0M -$207.1M
Total Stockholders' Equity -$1.83M -$1.09M $822K $6.67M $6.35M $9.78M $11.13M $19.13M
Total Equity -$1.83M -$1.09M $822K $6.67M $6.35M $9.78M $11.13M $19.13M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$26.26M -$41.84M -$29.49M -$35.71M -$28.30M -$19.21M -$44.57M -$27.18M -$84.59M -$82.26M
Depreciation & Amortization $266K $389K $381K $638K $374K $339K $97K $32K $1.65M $2.24M
Stock-Based Compensation $3.12M $5.30M $2.55M $1.56M $1.10M $453K $4.32M $1.43M $6.89M $9.21M
Change in Payables -$1.41M $1.60M -$263K $1.0K -$209K -$574K -$469K $320K $68K -$1.18M
Operating Cash Flow -$26.82M -$33.03M -$27.36M -$31.07M -$25.96M -$19.02M -$41.22M -$23.65M -$20.34M -$61.73M
Capital Expenditure $0 -$435K -$170K -$562K -$135K -$50K -$397K -$36K -$4.0K -$2.59M
Free Cash Flow -$26.82M -$33.46M -$27.53M -$31.63M -$26.09M -$19.07M -$41.62M -$23.68M -$20.34M -$64.32M
Acquisitions, Net -- -- -- -- -- -- $0 -$524K $462K --
Investing Cash Flow $0 -$435K -$170K -$562K -$97K -$6.0K $3.99M $1.93M $458K $8.29M
Common Stock Issued $6.04M $28.59M $35.60M $8.86M $33.42M $0 $26.69M $0 $0 $53.92M
Financing Cash Flow $4.26M $24.50M $35.60M $11.40M $59.06M $34.60M $26.94M $77.74M -$4.46M $54.15M
Net Change in Cash -$22.56M -$8.96M $8.07M -$20.23M $33.01M -$24.85M -$10.26M $56.15M -$24.33M --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$3.63M -$5.24M -$27.70M -$4.02M -$3.51M -$7.87M -$10.86M -$13.81M
Depreciation & Amortization $57K $59K $60K $65K $66K $67K $68K $49K
Stock-Based Compensation -$54K -$117K $226K $576K $61K $1.09M $1.39M $1.33M
Change in Payables $36K $1.41M -$454K $116K -$3.79M $2.53M -$263K $753K
Operating Cash Flow -$2.05M -$2.78M -$7.60M -$3.57M -$6.78M -$8.43M -$8.04M -$10.15M
Capital Expenditure -- $0 $0 $0 $0 $0 $0 -$3.0K
Free Cash Flow -- -$2.78M -$7.60M -$3.57M -$6.78M -$8.43M -$8.04M -$10.15M
Investing Cash Flow -- $0 $0 $0 $0 $0 $0 -$3.0K
Common Stock Issued -- -- -- $1.03M $0 $3.57M $1.44M $20.15M
Financing Cash Flow $2.17M $1.75M $1.70M $3.77M $13K $1.20M -$721K $17.95M
Net Change in Cash $118K -$1.03M -$5.90M $193K -$6.77M -$7.23M -$8.76M $7.80M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- -- -- -- -- -- -167.8% -727.1%
Operating Margin -- -- -- -- -- -- -- -- -28585.1% -12406.1%
Net Profit Margin -- -- -- -- -- -- -- -- -28670.5% -12597.2%
Return on Equity (ROE) -393.9% -218.8% -110.2% -197.2% -78.4% -- -- -38.3% -- -76.0%
Return on Assets (ROA) -155.1% -100.9% -57.1% -77.5% -38.6% -84.0% -59.4% -32.3% -426.9% -67.1%
Current Ratio 2.50x 2.21x 4.29x 4.53x 3.44x 6.15x 5.68x 8.50x 4.82x 8.82x
Quick Ratio 2.33x 2.13x 4.17x 4.29x 2.59x 12.01x 5.07x 7.91x 16.43x 8.66x
Debt to Equity 1.22x 0.80x 0.77x 1.22x 0.51x -- -- 0.01x -- --
Revenue Growth (YoY) -- -- -- -- -- -- -- -- -54.8% +135.7%

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -- -- -5243.1% -393.9% -568.1% -440.5% -402.4% -218.8%
Return on Assets (ROA) -463.3% -420.1% -401.0% -155.1% -210.5% -176.0% -139.3% -100.9%
Current Ratio 0.34x 0.38x 0.74x 2.50x 2.30x 2.11x 1.70x 2.21x
Quick Ratio 0.19x 0.18x 0.55x 2.33x 2.13x 2.00x 1.63x 2.13x
Debt to Equity -- -- 9.55x 1.22x 1.32x 0.89x 1.18x 0.80x
Source: SEC EDGAR CompanyFacts (CIK 0001544227) · from June 30, 2011 Data through September 30, 2026 · synced Nov 21, 2026, 05:08 UTC · Open in terminal